Correlation Between HUTCHMED DRC and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Abcellera Biologics, you can compare the effects of market volatilities on HUTCHMED DRC and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Abcellera Biologics.
Diversification Opportunities for HUTCHMED DRC and Abcellera Biologics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between HUTCHMED and Abcellera is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Abcellera Biologics go up and down completely randomly.
Pair Corralation between HUTCHMED DRC and Abcellera Biologics
Considering the 90-day investment horizon HUTCHMED DRC is expected to under-perform the Abcellera Biologics. But the stock apears to be less risky and, when comparing its historical volatility, HUTCHMED DRC is 1.67 times less risky than Abcellera Biologics. The stock trades about -0.13 of its potential returns per unit of risk. The Abcellera Biologics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 273.00 in Abcellera Biologics on September 2, 2024 and sell it today you would earn a total of 28.00 from holding Abcellera Biologics or generate 10.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HUTCHMED DRC vs. Abcellera Biologics
Performance |
| Timeline |
| HUTCHMED DRC |
| Abcellera Biologics |
HUTCHMED DRC and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HUTCHMED DRC and Abcellera Biologics
The main advantage of trading using opposite HUTCHMED DRC and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| HUTCHMED DRC vs. ANI Pharmaceuticals | HUTCHMED DRC vs. Phibro Animal Health | HUTCHMED DRC vs. Prestige Brand Holdings | HUTCHMED DRC vs. Pacira BioSciences, |
| Abcellera Biologics vs. Tff Pharmaceuticals | Abcellera Biologics vs. Eliem Therapeutics | Abcellera Biologics vs. Inhibrx | Abcellera Biologics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance |